Repeat-work pilot · Repeat-File Evidence Desk
Can ten repeat files be assessed against the same source and exception standard?
The buyer’s decision
Buyer: Food makers, retail buyers, brands and distributors. Decision trigger: Recall, label change, supplier change or export.
Defined unit: Written pilot of up to ten defined file types, with sampling rules, turnaround assumptions and exclusions.
Research emphasis: Reconcile public product, manufacturer and regulatory notice histories.. Records prioritised include FDA recall database, FSIS recall bulletin, manufacturer label.
Exactly what is investigated
- Confirm exact subject, legal identity and the limited research period
- Recover the agreed original records and record publication, effective and collection dates
- Which dated original FDA recall database most directly proves the key assertion concerning repeat-file evidence desk?
- Could same-name manufacturer alter the proposed decision, and which record would disprove it?
- Test adverse or alternative evidence and distinguish absence of evidence from a negative finding
- Construct a traceable label claim ledger for this decision
- Record the specific unavailable evidence and clarify what would change the conclusion
Deliverable and quality control
- Consistent file-by-file evidence cards, exception register and consolidated management view.
- label claim ledger using traceable sources
- Dated and classified findings: supported, contradicted, unresolved or out of scope
- Human review of source-to-claim traceability and privacy considerations
- Concisely stated reliance limitations and decision-owner questions
Boundary, cost and acceptance
Commercial rule: Fixed scope and fixed fee agreed in writing, with human acceptance before work begins. A fee amount is not yet approved for publication. No automatic checkout, blanket monitoring commitment, performance guarantee or prepaid credits.
- No laboratory food safety test, medical advice or conformity certification.
- Unlimited records, new jurisdictions, third-party licensed datasets and urgent handling unless contracted
- Final legal, accounting, medical, security, engineering, valuation or regulated sign-off
For a faster decision, commission the narrowest product that can resolve the immediate evidence question. Larger dossiers are optional and should follow a documented need.
Evidence starting points and what they do not prove
These databases and materials are starting points only. We do not claim that a named buyer, project, company or occurrence has been verified on this page.
- U.S. FDA device recall public API Official or industry source for use if relevant, not evidence of a named case
- openFDA status and data currency Official or industry source for use if relevant, not evidence of a named case
- FDA drug enforcement data Official or industry source for use if relevant, not evidence of a named case
Written commissioning
Request Repeat-work pilot · Repeat-File Evidence Desk Choose your decision stageDefined evidence, not an unlimited research engagement
Decision-specific checks
- Do product manufacturer, label and safety assertions match authoritative notices?
- Independent contrary-source check and named source version/date
- Explicit not-observed / outside-mandate decision
What to provide
- Exact subject identifier and jurisdiction
- Decision date, quoted claim or document
- Permitted supporting evidence and known contrary claims
Illustrative delivery components
File cards and exception dashboard and a source index stating record ID, issuer, effective date, read date and unresolved matters.
Professional reliance limit
No laboratory food safety test, medical advice or conformity certification.
Illustrative specification only. No factual conclusion or cleared buyer has been represented. Written scope, fee and researcher acceptance are required.
Evidence before commitment · clearly bounded
A specific answer for a specific decision
Know what the evidence supports before the next step.
What the review checks
What you supply
A human-reviewed source and contradiction assessment. No general AI answer is accepted as independent evidence. Scope, actual source availability, exclusions, fixed fee and delivery date are agreed in writing before work begins.
This specimen describes the method and possible deliverables. It is not a completed client investigation and contains no case findings.
